ArticleOncotarget2015

Multiple receptor tyrosine kinase activation attenuates therapeutic efficacy of the fibroblast growth factor receptor 2 inhibitor AZD4547 in FGFR2 amplified gastric cancer.

Jinjia Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.